Tel Aviv University breaks new ground in cancer detection, treatment with new innovation
The researchers predicted that the new tool will enable the development of personalized therapeutics by monitoring PTEN activity in various biological settings.
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019.(photo credit: PETER NICHOLLS/REUTERS)ByJERUSALEM POST STAFF